Home
Contact Us
Log In
About Us
History
Facts & Figures
Network
Management Team
Investment Committee
Portfolio
Portfolio At A Glance
Neupogen / Neulasta
Remicade
Humira
Rituxan
Atripla / Truvada / Emtriva
Thalomid
Lyrica
Prezista
Letairis / Volibris
RotaTeq
Cubicin
Savella
Myozyme / Lumizyme
Lexiscan
Januvia / Janumet
Onglyza / Kombiglyze
Galvus / Eucreas
Nesina
Tradjenta
TOBI
Viviant
Cimzia
Mircera
Vosaroxin
Tecfidera
Conbriza/Aprela
Approach
Investment Criteria
Investment Process
Case Studies
Resource Center
Royalties Explained
Royalty Valuation
Royalty Market Overview
Benefits of Monetization
News & Events
Press Releases
Proposed Offer for Elan
Calendar of Events
15th Anniversary
Contact Us
Financing
Business Affairs/Legal
Investor Relations
Business Development
Address & Direction
Home
Contact Us
Business Development
Contact Us
Financing
Business Affairs/Legal
Investor Relations
Business Development
Address & Direction
Royalty Pharma
110 East 59th Street
33rd Floor
New York, NY 10022
(212) 883-0200
(212) 883-2260 Fax
For Business Development
Jim Reddoch
This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
(212) 883-2280